Biotechnology

Elephas
Madison

Elephas’ Cybrid platform is the only platform in the world that utilizes live human tumor, with the native architecture and tumor microenvironment, to predict response to therapy. Elephas’ patented tumor fragmenting and sorting processes preserve the vital cell functions necessary to understand how a drug will interact with a tumor in the body.